APO-LEFLUNOMIDE leflunomide 20mg tablets bottle

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

leflunomide, Quantity: 20 mg

제공처:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Leflunomide

약제 형태:

Tablet, uncoated

구성:

Excipient Ingredients: colloidal anhydrous silica; lactose; magnesium stearate; crospovidone

관리 경로:

Oral

패키지 단위:

30 tablets

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Apo-Leflunomide is indicated for the treatment of active rheumatoid arthritis. The combined use of Apo-Leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

제품 요약:

Visual Identification: White, arc-triangular shaped tablet. Engraved "LE" over "20" on one side and "APO" on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

승인 상태:

Licence status A

승인 날짜:

2011-07-22